These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
179 related items for PubMed ID: 9146665
1. Vascular endothelial growth factor (VEGF) expression in human prostate cancer: in situ and in vitro expression of VEGF by human prostate cancer cells. Ferrer FA, Miller LJ, Andrawis RI, Kurtzman SH, Albertsen PC, Laudone VP, Kreutzer DL. J Urol; 1997 Jun; 157(6):2329-33. PubMed ID: 9146665 [Abstract] [Full Text] [Related]
2. Angiogenesis and prostate cancer: in vivo and in vitro expression of angiogenesis factors by prostate cancer cells. Ferrer FA, Miller LJ, Andrawis RI, Kurtzman SH, Albertsen PC, Laudone VP, Kreutzer DL. Urology; 1998 Jan; 51(1):161-7. PubMed ID: 9457313 [Abstract] [Full Text] [Related]
16. Vitamin E and the Y4 agonist BA-129 decrease prostate cancer growth and production of vascular endothelial growth factor. Yu A, Somasundar P, Balsubramaniam A, Rose AT, Vona-Davis L, McFadden DW. J Surg Res; 2002 Jun 01; 105(1):65-8. PubMed ID: 12069504 [Abstract] [Full Text] [Related]
19. Expression of vascular endothelial growth factor-A in human lymph node metastases of prostate cancer. Ismail AH, Altaweel W, Chevalier S, Kassouf W, Aprikian AG. Can J Urol; 2004 Feb 01; 11(1):2146-50. PubMed ID: 15003156 [Abstract] [Full Text] [Related]
20. Angiogenesis by fibroblast growth factor 4 is mediated through an autocrine up-regulation of vascular endothelial growth factor expression. Deroanne CF, Hajitou A, Calberg-Bacq CM, Nusgens BV, Lapière CM. Cancer Res; 1997 Dec 15; 57(24):5590-7. PubMed ID: 9407972 [Abstract] [Full Text] [Related] Page: [Next] [New Search]